Biomoda Adds Clinical Site To Lung Cancer Study
Links shared publicly online about this topic.
- 581total visits
Biomoda Adds Clinical Site To Lung Cancer Study
Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) announced that Waterbury Pulmonary Associates Research has joined the pilot clinical study of Biomoda's CyPath® diagnostic assay. Waterbu
View full resource at medicalnewstoday.com
Tags: Cancer, Lung Cancer, Lung, Pulmonology
Most Recently Shared on January 15, 2011 at 2:00 am By:
Biomoda Adds Clinical Site To Lung Cancer Study: Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) announce... http://mnt.to/f/3PYV
Also Shared By:
Advertisement
Lungs and Breathing
@Lung_Breathing
Biomoda Adds Clinical Site To Lung Cancer Study: Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) announce... http://mnt.to/f/3PYV
1 year ago...